Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 13, Issue 11

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 13, Issue 11 (2004)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 13, Issue 11 (2004)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Volume 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Review

Review Article

Peroxisome proliferator-activated receptor ligands in atherosclerosis

Juan F Viles-Gonzalez, Brian G Choi, Valentin Fuster & Juan J Badimon

Pages: 1393-1403

Published online: 24 Feb 2005

AbstractforPeroxisome proliferator-activated receptor ligands in atherosclerosis | References | PDF (253.1 KB)

56 Views
6 CrossRef citations
0Altmetric

Review Article

Lipid-lowering therapies in development

Anthony S Wierzbicki

Pages: 1405-1418

Published online: 24 Feb 2005

AbstractforLipid-lowering therapies in development | References | PDF (192.6 KB)

57 Views
6 CrossRef citations
0Altmetric

Review Article

The potential of endothelin antagonism as a therapeutic approach

Ariela Benigni, Norberto Perico & Giuseppe Remuzzi

Pages: 1419-1435

Published online: 24 Feb 2005

AbstractforThe potential of endothelin antagonism as a therapeutic approach | References | PDF (213.6 KB)

41 Views
12 CrossRef citations
0Altmetric

Review Article

The analgesic potential of clostridial neurotoxin derivatives

Keith A Foster

Pages: 1437-1443

Published online: 24 Feb 2005

AbstractforThe analgesic potential of clostridial neurotoxin derivatives | References | PDF (129.1 KB)

64 Views
14 CrossRef citations
0Altmetric

Review Article

Recent developments in transient receptor potential vanilloid receptor 1 agonist-based therapies

Keith R Bley

Pages: 1445-1456

Published online: 24 Feb 2005

AbstractforRecent developments in transient receptor potential vanilloid receptor 1 agonist-based therapies | References | PDF (266.5 KB)

152 Views
76 CrossRef citations
0Altmetric

Review Article

Selective oestrogen receptor modulators in desmoid tumours

Lucia Picariello, Francesco Tonelli & Maria Luisa Brandi

Pages: 1457-1468

Published online: 24 Feb 2005

AbstractforSelective oestrogen receptor modulators in desmoid tumours | References | PDF (151.9 KB)

115 Views
25 CrossRef citations
0Altmetric

Review Article

The potential role of non-steroidal anti-inflammatory drugs in treating Alzheimer’s disease

Bruno P Imbimbo

Pages: 1469-1481

Published online: 24 Feb 2005

AbstractforThe potential role of non-steroidal anti-inflammatory drugs in treating Alzheimer’s disease | References | PDF (171.8 KB)

164 Views
41 CrossRef citations
0Altmetric

Drug Evaluation

Article

Sitaxsentan, a selective endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension

Evelyn M Horn, Allison C Widlitz & Robyn J Barst

Pages: 1483-1492

Published online: 24 Feb 2005

AbstractforSitaxsentan, a selective endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension | References | PDF (178.1 KB)

61 Views
15 CrossRef citations
0Altmetric

Article

Darifenacin: a novel M₃ muscarinic selective receptor antagonist for the treatment of overactive bladder

Christopher R Chapple

Pages: 1493-1500

Published online: 24 Feb 2005

AbstractforDarifenacin: a novel M₃ muscarinic selective receptor antagonist for the treatment of overactive bladder | References | PDF (112.4 KB)

248 Views
29 CrossRef citations
0Altmetric

Article

CT-2103: emerging utility and therapy for solid tumours

Corey J Langer

Pages: 1501-1508

Published online: 24 Feb 2005

AbstractforCT-2103: emerging utility and therapy for solid tumours | References | PDF (127.6 KB)

85 Views
17 CrossRef citations
0Altmetric

Miscellaneous

Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III – IV congestive heart failure

Ronald S Freudenberger, Richard P Schwarz Jr, Joanne Brown, Alan Moore, Douglas Mann, Michael M Givertz, Wilson S Colucci & Joshua M Hare

Pages: 1509-1516

Published online: 24 Feb 2005

AbstractforRationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III – IV congestive heart failure | References | PDF (100 KB)

88 Views
39 CrossRef citations
0Altmetric

A neuroprotective derivative of erythropoietin that is not erythropoietic

Sheila A Doggrell

Pages: 1517-1519

Published online: 24 Feb 2005

AbstractforA neuroprotective derivative of erythropoietin that is not erythropoietic | References | PDF (60.7 KB)

101 Views
13 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Inflammation and Huntington’s disease- a neglected therapeutic target?

Sophie E. Field et al.

Review Article | Published online: 17 May 2024

Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 14 May 2024

Emerging therapies for overactive bladder: preclinical, phase I and phase II studies

Samantha Gibson et al.

Review Article | Published online: 9 May 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 9 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.13, Iss.11, 2004)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?